Miami, FL (PRWEB) December 18, 2013
bioRASI is featured in case study by marcus evans Summits. marcus evans Summits are exclusive gatherings of the industry leaders of big pharma and advanced biotech in clinical development where they discuss the best practices and future of clinical research.
“Our participation at marcus evans Summits has provided opportunities to demonstrate how innovative and advanced our bioRASI Process Infrastructure (BPI) is,” said Dr. Boris Reznik, Chairman of bioRASI. “The Evolution Summits are perfect venues for in depth discussions and analysis of BPI concepts, features and future enhancement paths. Having the industry leader’s participation is what makes BPI transcend the industry’s best practices to a totally different level.”
BPI is a robust operating platform of integrated systems, tools and processes that assures optimal execution of clinical trials. It is also a powerful training tool that allows bioRASI to on board new personnel quickly and seamlessly integrate them into our process. BPI is continuously being improved and the BPI V14 will be released next month.
bioRASI is an award-winning Clinical Research Optimized™ CRO. From study design to execution success, optimization is engrained in our bioRASI Process Infrastructure (BPI), the most robust and innovative operating platform in the industry. Equipped with BPI, our full service project teams have developed numerous drugs, biologics and medical devices that received FDA and multi-venue approvals. bioRASI is headquartered in Miami, FL and has regional offices and operations across North America and around the world.